BOSTON SCIENTIFIC CORPORATION Proceeds from (Repayments of) Other Long-term Debt
BOSTON SCIENTIFIC CORPORATION (BSX) reported Proceeds from (Repayments of) Other Long-term Debt of $1.92 billion for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt · last filed 2020-11-05
- BOSTON SCIENTIFIC CORPORATION proceeds from (repayments of) other long-term debt for the quarter ending 2020-09-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION proceeds from (repayments of) other long-term debt for the quarter ending 2020-06-30 was $77.00M.
- BOSTON SCIENTIFIC CORPORATION proceeds from (repayments of) other long-term debt for the quarter ending 2020-03-31 was $1.84B.
- BOSTON SCIENTIFIC CORPORATION proceeds from (repayments of) other long-term debt for the quarter ending 2019-09-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION proceeds from (repayments of) other long-term debt for fiscal 2010 was $973.00M, a 50.66% decline from fiscal 2009.
- BOSTON SCIENTIFIC CORPORATION proceeds from (repayments of) other long-term debt for fiscal 2009 was $1.97B.
| Period end | Proceeds from (Repayments of) Other Long-term Debt 3 month | Proceeds from (Repayments of) Other Long-term Debt 6 month | Proceeds from (Repayments of) Other Long-term Debt 9 month | Proceeds from (Repayments of) Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $77.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.92B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $77.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.92B 10-Q · filed 2020-08-05 | ||
| 2020-03-31 | $1.84B 10-Q · filed 2020-05-06 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-06 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $0.00 derived: sum of 2 quarters · filed 2011-02-17 | $973.00M 10-K · filed 2011-02-17 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $973.00M 10-Q · filed 2010-11-05 | ||
| 2010-06-30 | $973.00M 10-Q · filed 2010-08-05 | |||
| 2009-12-31 | $1.97B 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |